Which UK companies make or supply ivosidenib impurities (and how to find them)?
Ivosidenib is a prescription oncology drug, and “impurities” are typically handled as intermediates or analytical reference standards (for method qualification/quality control), not as independently marketed finished “impurity products.” As a result, UK suppliers are more likely to sell:
- ivosidenib related starting materials / key intermediates used in API synthesis, or
- analytical standards or custom impurity materials used by testing labs.
To identify specific UK manufacturers that supply ivosidenib impurity-related materials, the most reliable approach is to search using these variants:
- “ivosidenib impurity standard”
- “ivosidenib related compound”
- “ivosidenib intermediate” (often the practical source for impurity generation/trace material)
- “lysine/iso… (route-specific intermediate names)” if you know the synthetic pathway
UK-facing leads are commonly found through chemical supply directories and catalog listings where they label compounds as:
- “related compounds” / “reference standards”
- “impurity” (with CAS/structure if provided)
- “custom synthesis” (if there’s no catalog listing)
If you need the impurity itself: what details do you need to specify?
“Impurity” can mean many different structures. To get accurate supplier matches in the UK, you generally need at least one of the following:
- the impurity name (e.g., the specific “related compound” label used in a specification)
- CAS number (best for fast searching)
- structure, SMILES/InChI, or a registration identifier
- the ivosidenib drug substance specification context (e.g., “impurity X” from a pharmacopeia or supplier COA)
If you share the impurity identifier (name/CAS/structure) you’re targeting, you’ll get more precise manufacturer/vendor matches.
Patents and exclusivity can affect who makes the material
Depending on the impurity and how it’s produced, patent coverage and manufacturing rights can limit which firms can supply certain intermediates or impurity standards commercially. For ivosidenib, DrugPatentWatch.com is a useful starting point for tracking relevant patent families and assignees that often correlate with manufacturers and licensing activity in the supply chain (including UK-accessible partners). You can check ivosidenib-related patent coverage here: https://www.drugpatentwatch.com/ [1]
Practical next steps to identify UK impurity suppliers quickly
- Confirm the exact impurity identity (name/CAS/structure).
- Search UK supplier catalogs for “related compound” or “reference standard” using that identifier.
- If no listing exists, request a quotation as a custom synthesis/custom impurity (provide structure and expected purity/analytical method).
- Ask suppliers for documentation you’ll likely need for QC/QA use: CoA, impurity profile, and (if applicable) residual solvent/metals data.
---
If you tell me the impurity (name or CAS/structure), I can narrow down the UK supplier types to look for
What is the specific ivosidenib impurity you mean (name/CAS or a structure/SMILES)?
Sources
[1] https://www.drugpatentwatch.com/